ISDA

Deposition Date 2012-02-16

Release Date 2012-03-21

Last Version Date 2024-05-01

Entry Detail

PDB ID:

4AJL

Keywords:

OXIDOREDUCTASE/INHIBITOR

Title:

rat LDHA in complex with 3-(ethylcarbamoylamino)-N-(2-methyl-1,3- benzothiazol-6-yl)propanamide

Biological Source:

Source Organism:

RATTUS NORVEGICUS (Taxon ID: 10116)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.77 Å

R-Value Free:

0.18

R-Value Work:

0.14

R-Value Observed:

0.14

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:L-LACTATE DEHYDROGENASE A CHAIN
Gene (Uniprot):Ldha
Chain IDs:A, B, C, D
Chain Length:331
Number of Molecules:4
Biological Source:RATTUS NORVEGICUS

UniProt ID:P04642 Pfam ID:PF00056, PF02866

Ligand Molecules

88W

DMS

GOL

MLI

Primary Citation

The Design and Synthesis of Novel Lactate Dehydrogenase a Inhibitors by Fragment-Based Lead Generation

Ward, R, Brassington, C, Breeze, A.L, Caputo, A, Critchlow, S, Davies, G, Goodwin, L, Hassall, G, Greenwood, R, Holdgate, G, Mrosek, M, Norman, R.A, Pearson, S, Tart, J, Tucker, J.A, Vogtherr, M, Whittaker, D, Wingfield, J, Winter, J, Hudson, K.Show

J.Med.Chem. 55 3285 ? (2012)

PMID: 22417091 DOI: 10.1021/JM201734R

Abstact

Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor. It has been identified as a potential therapeutic target in the area of cancer metabolism. In this manuscript we report our progress using fragment-based lead generation (FBLG), assisted by X-ray crystallography to develop small molecule LDHA inhibitors. Fragment hits were identified through NMR and SPR screening and optimized into lead compounds with nanomolar binding affinities via fragment linking. Also reported is their modification into cellular active compounds suitable for target validation work.

Legend

Protein

Chemical

Disease

Primary Citation of related structures